NCT04513613

ACHIEVE GRX Registry

A Post-Market Registry for the Evaluation of the CorPath® GRX System Effectiveness in Peripheral Vascular Interventions

• Status: Withdrawn
• Phase: —
• Study type: Observational
• Enrollment: 0 (actual)
• Sponsor: Corindus Inc. · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study will evaluate real-world performance of the CorPath GRX System in peripheral vascular interventions.

Detailed description

This is a prospective, single-arm, open-label, multi-center registry of the CorPath GRX System to evaluate its real-world performance during peripheral vascular interventions.

Conditions

• Peripheral Arterial Disease
• Peripheral Vascular Diseases
• Renal Artery Disease
• Carotid Artery Diseases

Interventions

Type	Name	Description
DEVICE	Procedure/Surgery: Robotic-PVI	Robotic-assisted (CorPath GRX System) percutaneous vascular interventions.

Timeline

• Start date: 2022-01-01
• Primary completion: 2023-01-01
• Completion: 2023-01-01
• First posted: 2020-08-14
• Last updated: 2021-04-23

Regulatory

• FDA-regulated device study